1College of Integrated Chinese and Western Medicine,Changchun University of Chinese Medicine, 2Nephropathy Department,the Affiliated Hospital to Changchun University of Chinese Medicine, 3College of Traditional Chinese Medicine,Changchun University of Chinese Medicine, 4Internal Medicine Intensive Care Unit,the Affiliated Hospital to Changchun University of Chinese Medicine
Summary
The present protocol describes the establishment of a membranous nephropathy (MN) animal model, and how Kemeng Fang’s inhibition reduces MN rat podocyte apoptosis by activating the PI3K/AKT signaling pathway.
